Literature DB >> 12850324

A tale of two necessities: breakaway technology versus diabetes.

Matt Brown.   

Abstract

Diabetes is endemic in industrialized society. A new technology is being used to uncover molecules that block a key enzyme in the diabetes disease mechanism.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12850324     DOI： 10.1016/s1359-6446(03)02770-3

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN： 1359-6446            Impact factor:   7.851


  1 in total

1.  Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats.

Authors:  Yong Wu; Jing Ping Ouyang; Ke Wu; Shi Shun Wang; Chong Yuan Wen; Zheng Yuan Xia
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.